Srikant Datar - STRYKER Independent Director

SYK Stock  EUR 364.80  7.40  1.99%   

Director

Dr. Srikant M. Datar, Ph.D., is Independent Director of the Company. Arthur Lowes Dickinson Professor at the Graduate School of Business Administration of Harvard University since 1996. Faculty Chair of the Harvard Innovation Labs and Senior Associate Dean for University Affairs. From 1989 to 1996, he was Edmund W. Littlefield Professor at the Graduate School of Business, Stanford University. Dr. Datar is also a director of Novartis AG, a multinational pharmaceutical and consumer health products company, ICF International, Inc., a management, technology and policy consulting firm, and TMobile US, Inc., a provider of wireless voice, messaging and data services since 2009.
Age 66
Tenure 15 years
Datar has an extensive background in accounting and finance and a variety of other business areas, including organization design and performance measurement. His strong academic and business background and his experience on the board committees of other companies allow him to make significant contributions to our committees. His service on the boards of global companies involved in pharmaceuticals and high tech gives him great insights into assessing the Company technology and strategies to expand our business globally.
STRYKER (SYK) is traded on Berlin Exchange in Germany and employs 35 people.

STRYKER Leadership Team

Elected by the shareholders, the STRYKER's board of directors comprises two types of representatives: STRYKER inside directors who are chosen from within the company, and outside directors, selected externally and held independent of STRYKER. The board's role is to monitor STRYKER's management team and ensure that shareholders' interests are well served. STRYKER's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, STRYKER's outside directors are responsible for providing unbiased perspectives on the board's policies.
Andrew Silvernail, Independent Director
Sherilyn McCoy, Independent Director
Ronda Stryker, Independent Director
Rajeev Suri, Independent Director
Preston Wells, Vice President - Investor Relations
Glenn Boehnlein, Chief Financial Officer, Vice President
Viju Menon, Group President - Global Quality and Business Operations
William Berry, Principal Accounting Officer, Vice President Corporate Controller
Allan Golston, Lead Independent Director
Mary Brainerd, Independent Director
Srikant Datar, Independent Director
Kevin Lobo, Chairman of the Board, Chief Executive Officer
Giovanni Caforio, Director
Roch Doliveux, Independent Director
Yin Becker, Vice President - Communications, Public Affairs and Corporate Marketing
M Fink, Chief Human Resource Officer, Vice President
Timothy Scannell, Group President - MedSurg and Neurotechnology
Robert Fletcher, Vice President Chief Legal Officer

STRYKER Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is STRYKER a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in STRYKER Stock

When determining whether STRYKER is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if STRYKER Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRYKER. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade STRYKER Stock refer to our How to Trade STRYKER Stock guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Please note, there is a significant difference between STRYKER's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRYKER is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRYKER's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.